top of page
Search


Personal value of Alzheimer's disease biomarker testing
The personal utility outcomes of the IMPACT-AD BC study have now been peer-reviewed and published in one of the leading journals in the...
Aug 1, 2024


Clinical value of Alzheimer's disease biomarker testing
Findings from the IMPACT-AD BC study.
Aug 1, 2024


A national leader in Alzheimer’s care
A major success of the Canadian IMPACT-AD study was the launch, in 2021, of the national Alzheimer's disease biomarker testing program....
Jul 25, 2024


Understanding frontotemporal dementia
IMPACT-AD study investigator Dr. Robin Hsiung talks about frontotemporal dementia on the Global TV News Health Matters series....
Feb 17, 2023
bottom of page